Skip to content
PICO Portalanswers from OpenAlex

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria

PaperCitations, authors & open-access status

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria is a paper indexed in PICO Portal from OpenAlex.

How many citations does Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria have?

PICO Portalcitation count

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria has 203 citations in the OpenAlex counts PICO Portal stores.

When was Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria published?

PICO Portalyear

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria has 2010 year in the PICO Portal index.

What is the open-access status of Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria?

PICO Portaloa status

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria has bronze oa status in the PICO Portal index.

What is the DOI of Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria?

PICO Portaldoi

The DOI for Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria is on the source record.

What is the PMID of Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria?

PICO Portalpmid

The PMID for Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria is on the source record.

What is the OpenAlex record for Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria?

PICO Portalopenalex

The OpenAlex for Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial